AEYE-X is an advanced, one-of-its-kind AI platform for comprehensive health assessment of over 100 conditions using retinal imaging. By examining one-image-per-eye of the retina, the system can identify cardiovascular, ocular, vision and even cognitive indications. AEYE-X is the best-in-class system both in its level of science and broadness of indications is backed by AEYE’s research and publications. The platform is camera-agnostic and it can be seamlessly integrated with various existing retinal hardware to provide real-time diagnostic results in under 1 minute.
Turn a single retinal scan into a comprehensive health screening
AEYE-X combines point-of-care disease detection with systemic risk forecasting using a single non-dilated image per eye. In under 1-minute, care teams can diagnose active ocular conditions and uncover early indicators of broader systemic disease, delivering actionable health insights, long before symptoms appear.
CAUTION: Federal (US) law restricts this device to investigational use only.
NOT SOLD IN THE US
How AEYE-X turns one retinal image
into a comprehensive health assessment
AEYE-X delivers instant diagnostic findings and early risk signals for a wide range of health conditions using autonomous AI. By leveraging the retina as the body's only non-invasive window into blood vessels and neural structure, AEYE-X brings the power of advanced oculomics directly to the point of care, backed by best-in-class research.
Staff capture 1-image per-eye using an indicated camera. AEYE-X is camera-agnostic and runs on portable and tabletop hardware you may already own.
AI analyzes the image across multiple condition-specific models in parallel, extracting real-time findings and early risk signals.
A comprehensive health assessment is returned in under a minute, enabling providers to deliver actionable health insights immediately.
A growing panel from a
single image
AEYE-X is designed to detect and assess risk across more than 100 clinical indications from a single retinal scan, supported by peer-reviewed research and clinical validation studies. The capabilities group into four pillars.
-
Chronic ocular disease
Early detection and monitoring of sight-threatening conditions, including diabetic retinopathy, glaucoma, AMD, and retinal vascular occlusions.
-
Systemic and vascular risk
Cardiovascular risk, diabetes progression, cholesterol, blood pressure, and chronic kidney disease.
-
Cognitive health and neurology
Risk profiling for neurodegenerative conditions, including dementia and cognitive decline.
-
Vision and refractive assessment
Refractive error (spherical and cylindrical), visual acuity estimates, and correctable vision potential.
Maximum health insights from a fast, patient-friendly
exam
AEYE-X unlocks the full diagnostic potential of every scan, giving clinicians broad-spectrum health intelligence from an exam patients already easily accept.
AEYE-X can detect and also predict the development of conditions before clinical symptoms appear, providing a window for early intervention and prevention.
health findings
Assess a single non-dilated scan across a broad panel of ocular and systemic conditions, delivering multi-disease intelligence from a single point of capture.
Autonomous AI delivers a comprehensive health assessment directly at the point of care, eliminating the need for multiple specialist referrals and capturing at-risk patients who would otherwise fall through the cracks.
Working with research and health system
partners worldwide
FAQ
A single image per-eye, a
comprehensive health assessment
Discover how AEYE-X transforms routine imaging into broad-spectrum health intelligence.